Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Schleich, J. Dallinga, M. Henket, A. Boots, E. Wouters, R. Louis, F. J. van Schooten (Liege, Belgium; Maastricht, Netherlands). Do volatile organic compounds discriminate between eosinophils and neutrophils in vitro?. Eur Respir J 2012; 40: Suppl. 56, 4308

Member's Comments

No comment yet.

Related content which might interest you: Detection of volatile organic compounds in cattle caturally infected with Mycobacterium bovis Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Diet and alcohol affect exhaled volatile organic compounds (VOCs) Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Standardization of exhaled volatile organic compounds (VOCs) measurement Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Interpretation of exhaled volatile organic compounds Source: Eur Respir Monogr 2010; 49: 115-129 Year: 2010 Exposure to volatile organic compounds and loss of pulmonary function in the elderly Source: Eur Respir J 2010; 36: 1270-1276 Year: 2010 Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Volatile organic compound (VOC) analysis to differentiate between bacterial and viral respiratory infections in COPD Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Organic dust-induced interleukin-12 production activates T- and natural killer cells Source: Eur Respir J 2002; 20: 686-690 Year: 2002 Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Microbial volatile organic compounds (MVOC) and plasticizers in schools in relation to asthma and respiratory symptoms among pupils Source: Eur Respir J 2006; 28: Suppl. 50, 698s Year: 2006